neurological diseases, nervous system diseases neurological diseases, nervous system diseases
Conditions
Interventions
None listed
Sponsors
Kato Yoichi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Individuals who did not experience satisfactory treatment effects with standard therapy. 2. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and whose physicians have determined that treatment with conditioned medium is appropriate. Inclusion criteria for patients are as follows: Patients meeting the following criteria are eligible: 1. Individuals aged 18 years or older. 2. Individuals with normal capacity to consent. 3. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily. 4. Individuals for whom the attending physician has recognized the necessity of treatment.
Exclusion criteria
Exclusion criteria: Individuals who meet any of the following conditions will be excluded: 1. Individuals who use narcotics or stimulants. 2. Individuals deemed inappropriate by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Conditions of the patient. Evaluate the symptoms of the neurological disorders by the appropriate score sheet. Central nervous system - Fugl-Meyer Assessment (FMA) - ALS Functional Rating Scale (ALSFRS-R) - Unified Parkinson's Disease Rating Scale (UPDRS) - Expanded Disability Status Scale (EDSS), etc Peripheral nervous system - Manual Muscle Testing (MMT) - Assessment of muscle atrophy - Tendon reflex - Gait Analysis, etc Chronic pain - Site of the pain - Brief Pain Inventory (BPI) MRI / CT as necessary | — |
Contacts
Public ContactYoichi Kato
Shin Yokohama Kato Clinic
Outcome results
None listed